Buyer caution around $4.55 level pushes Injective down 8.54%

Traders Union
All News
Crypto News
Injective drops 8.54% to $4.65 today

Highlights

INJ maintains a bullish structure above key moving averages, but strong intraday selling signals weakening buyer conviction.
Momentum indicators are mixed, with MACD and trends positive, but overbought oscillators and a sell signal from Stoch RSI indicate limited upside.
INJ is likely to trade sideways between $4.55 and $4.90 in the next five days, with further downside favored if support at $4.55 fails.

Bullish momentum faces overbought pressures and volatility divergence

On the technical front, INJ is trading above the SMA-20 ($4.08), SMA-50 ($3.46), and SMA-200 ($4.40), with the Ichimoku Kijun at $4.64 representing immediate support below the current price. MACD and ADX (daily chart) show ongoing bullish momentum, while the RSI stands at an elevated 73.62 and the CCI is also marked as overbought, indicating caution. The Stoch RSI delivers a strong sell signal at these levels, whereas BBP reflects continued buyer dominance. The Awesome Oscillator supports the prevailing bullish backdrop, but the presence of high intraday volatility, a move near today’s low, and divergence between strong intraday selling and D1 momentum suggest waning buyer conviction.

Downside risk rises amid low odds for breakout

Over the next five trading days, the expected range for INJ is $4.55–$4.90, reflecting typical volatility and current price proximity. A further rise is estimated at less than a 20% probability, indicating that downward movement is much more likely in the short term. Baseline scenario: INJ fluctuates sideways between $4.55 and $4.90. A break above $4.90 may trigger a retracement towards $5.00, while a move below $4.55 would expose further downside given current indicator readings and trend bias.

Viktoras Karapetjanc, expert at Traders Union, notes that Injective is showing resilience on the technical front despite today's steep drop. He sees bullish momentum indicators but observes signals of exhaustion and strong volatility. There is no fundamental news catalyst at the moment. Karapetjanc believes that downside risk is more likely in the coming days, yet underlying support persists above key averages. "Price action shows promise above $4.55, but I expect the next move to offer tactical entry chances only on further dips or a clear break above $4.90."

Earlier, analysts noted that Injective maintained a generally bullish technical structure despite heightened short-term downside risks and overbought signals. With current data showing persistent volatility and flagging buyer conviction, traders should monitor for any sustained move below $4.55 as a potential catalyst for deeper corrective action.

Source of Data: INJ Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.